Clinical trial
Response to Plasmodium Falciparum-Derived TLR Ligands in Severe and Uncomplicated Malaria in Mali
NCT00368810 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Response to Plasmodium Falciparum-Derived TLR Ligands in Severe and Uncomplicated Malaria in Mali
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 21, 2006
- Completion date
- November 30, 2006
- Enrollment
- 120
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.